Ventyx Biosciences Inc (VTYX) — Strategic Asset Allocation Index
Ventyx Biosciences Inc (VTYX) has a Strategic Asset Allocation Index of 0.0% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $191.36 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check VTYX asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Ventyx Biosciences Inc Strategic Asset Allocation Index (2021–2024)
This chart shows how Ventyx Biosciences Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $191.36 Million USD. See VTYX financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Ventyx Biosciences Inc (2021–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Ventyx Biosciences Inc from 2021 to 2024, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Ventyx Biosciences Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 14.0% | $35.62 Million | $- | $35.62 Million | $254.04 Million | ▲ +14.0 pp |
| 2023 | 0.0% | $0.00 | $- | $0.00 | $243.92 Million | ▼ -11.0 pp |
| 2022 | 11.0% | $39.08 Million | $407.00K | $38.67 Million | $353.89 Million | ▲ +0.9 pp |
| 2021 | 10.2% | $28.40 Million | $254.00K | $28.15 Million | $279.20 Million | — |